Dimethylamine enhances platelet hyperactivity in chronic kidney disease model

Association of Trimethylamine, Trimethylamine N-oxide, and Dimethylamine with Cardiovascular Risk in Children with Chronic Kidney Disease

(2020) Chien-Ning Hsu et al.   Journal of Clinical Medicine

Urinary Dimethylamine (DMA) and Its Precursor Asymmetric Dimethylarginine (ADMA) in Clinical Medicine, in the Context of Nitric Oxide (NO) and Beyond

(2020) Dimitrios Tsikas   Journal of Clinical Medicine

Circulating monocyte-platelet aggregates are a robust marker of platelet activity in cardiovascular disease

(2019) Nicole Allen et al.   ATHEROSCLEROSIS

Chronic Kidney Disease Diagnosis and Management

(2019) Teresa K. Chen et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Prevalence and Risk of Protein-Energy Wasting Assessed by Subjective Global Assessment in Older Adults With Advanced Chronic Kidney Disease: Results From the EQUAL Study

(2018) Karin Windahl et al.   JOURNAL OF RENAL NUTRITION

Role of Protein Kinase C-delta in regulating platelet activation and platelet-leukocyte interaction during sepsis

(2018) Elisabetta Liverani et al.   PLoS One

The role of trimethylamine N-oxide as a mediator of cardiovascular complications in chronic kidney disease

(2017) James A.P. Tomlinson et al.   KIDNEY INTERNATIONAL

Fish oil affects the metabolic process of trimethylamine N-oxide precursor through trimethylamine production and flavin-containing monooxygenase activity in male C57BL/6 mice

(2017) Jie Yu et al.   RSC Advances

Inhibition of Collagen-Induced Platelet Aggregation by the Secobutanolide Secolincomolide A from Lindera obtusiloba Blume

(2017) Sang-Hyuk Jung et al.   Frontiers in Pharmacology

Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis Risk

(2016) Weifei Zhu et al.   CELL

Distinctive roles of PKC delta isozyme in platelet function

(2016) Y. Zaid et al.   Current Research in Translational Medicine

Global Prevalence of Chronic Kidney Disease – A Systematic Review and Meta-Analysis

(2016) Nathan R. Hill et al.   PLoS One

Prevalence and Impact of High Platelet Reactivity in Chronic Kidney Disease: Results From the Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents Registry

(2015) U. Baber et al.   Circulation-Cardiovascular Interventions

Trimethylamine N-Oxide as a Novel Therapeutic Target in CKD

(2015) W. H. W. Tang   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Klotho Protects Against Indoxyl Sulphate-Induced Myocardial Hypertrophy

(2015) K. Yang et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Early chronic kidney disease: diagnosis, management and models of care

(2015) Olivier J. Wouters et al.   Nature Reviews Nephrology

Approaches to Uremia

(2014) T. W. Meyer et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Risk factors for atherosclerosis in patients with chronic kidney disease: recognition and management

(2013) Sudarshan Balla et al.   CURRENT OPINION IN PHARMACOLOGY

Intestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosis

(2013) Robert A Koeth et al.   NATURE MEDICINE

Normal and Pathologic Concentrations of Uremic Toxins

(2012) F. Duranton et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Colonic Contribution to Uremic Solutes

(2011) P. A. Aronov et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Adipocytokines in Atherothrombosis: Focus on Platelets and Vascular Smooth Muscle Cells

(2010) Giovanni Anfossi et al.   MEDIATORS OF INFLAMMATION

Diverse functions of protein kinase C isoforms in platelet activation and thrombus formation

(2009) M. T. HARPER et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

A multicolor flow cytometric assay for measurement of platelet-derived microparticles

(2009) Fariborz Mobarrez et al.   THROMBOSIS RESEARCH